Vanderbilt University Medical Center Post‐Graduate Year Two (PGY2) Pharmacy Residency program is a 12-month, full‐time residency, accredited by the American Society of Health‐System Pharmacists. The purpose of the residency is to develop a pharmacist with the skills and abilities to successfully practice as an oncology pharmacist, adjunct faculty member, and/or be prepared to pursue a clinical heme/oncology specialty pharmacist role. The mission of our program includes developing a core skill set in heme/oncology drug information and literature evaluation, pharmacotherapy evaluation and management, project-based research and team functioning, presentation development and delivery, and direct patient interaction. Residents are expected to obtain unrestricted licensure to practice in the State of Tennessee by July 31st of their residency year. Residents who are not fully licensed by this date may have modifications to their scheduled responsibilities. Failure to obtain licensure by October 1st will result in termination from the residency program and termination from employment at VUMC, unless licensure is anticipated within 120 days after the program start date. A final written warning will be issued to the resident if not fully licensed within the resident’s first 90 days of employment. Verification of licensure occurs in accordance with VUMC policy (Pharmacy Policy - Pharmacy Residency Program Standards v.6 (policytech.com)). Until residents obtain unrestricted licensure to practice in the State of Tennessee, all job functions will be supervised by a licensed pharmacist.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level